Functional analysis of interactions between Tat and the trans-activation response element of human immunodeficiency virus type 1 in cells
- PMID: 8350414
- PMCID: PMC237965
- DOI: 10.1128/JVI.67.9.5617-5622.1993
Functional analysis of interactions between Tat and the trans-activation response element of human immunodeficiency virus type 1 in cells
Abstract
Transcriptional trans-activation of the human immunodeficiency virus type 1 long terminal repeat requires that the virally encoded Tat effector interacts with its target trans-activation response element (TAR) RNA stem-loop. Although the arginine-rich region of Tat from amino acids 49 to 59 is sufficient to bind to TAR RNA in vitro, the RNA-binding domain of Tat has not been defined in vivo. Human immunodeficiency virus type 1 also encodes the Rev protein, which acts through an RNA stem-loop called the Rev-response element to transport unspliced and singly spliced viral RNA species from the nucleus to the cytoplasm. To map the RNA-binding domain of Tat, we performed assays that relied on Rev function using the heterologous RNA-tethering mechanism of Tat and the TAR. By examining the effects of selected targeted mutations of Tat on the abilities of hybrid Tat/Rev proteins to rescue the expression of unspliced mRNA via the TAR, we demonstrated that residues throughout the N-terminal 59 amino acids of Tat are required for binding of Tat and TAR RNA in vivo.
Similar articles
-
The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence.Genes Dev. 1992 Nov;6(11):2077-87. doi: 10.1101/gad.6.11.2077. Genes Dev. 1992. PMID: 1427073
-
Human immunodeficiency virus type 1 Rev activation can be achieved without Rev-responsive element RNA if Rev is directed to the target as a Rev/MS2 fusion protein which tethers the MS2 operator RNA.J Virol. 1992 Dec;66(12):7469-80. doi: 10.1128/JVI.66.12.7469-7480.1992. J Virol. 1992. PMID: 1433526 Free PMC article.
-
The number of positively charged amino acids in the basic domain of Tat is critical for trans-activation and complex formation with TAR RNA.Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):6234-8. doi: 10.1073/pnas.88.14.6234. Proc Natl Acad Sci U S A. 1991. PMID: 2068104 Free PMC article.
-
Biochemical and functional interactions between HIV-1 Tat protein and TAR RNA.Arch Biochem Biophys. 1999 May 15;365(2):175-85. doi: 10.1006/abbi.1999.1206. Arch Biochem Biophys. 1999. PMID: 10328810 Review.
-
Discoveries of Tat-TAR interaction inhibitors for HIV-1.Curr Drug Targets Infect Disord. 2005 Dec;5(4):433-44. doi: 10.2174/156800505774912901. Curr Drug Targets Infect Disord. 2005. PMID: 16535863 Review.
Cited by
-
Dynamic Post-Transcriptional Regulation of HIV-1 Gene Expression.Biology (Basel). 2012 Jul 3;1(2):116-33. doi: 10.3390/biology1020116. Biology (Basel). 2012. PMID: 24832221 Free PMC article.
-
The ability of positive transcription elongation factor B to transactivate human immunodeficiency virus transcription depends on a functional kinase domain, cyclin T1, and Tat.J Virol. 1998 Sep;72(9):7154-9. doi: 10.1128/JVI.72.9.7154-7159.1998. J Virol. 1998. PMID: 9696809 Free PMC article.
-
Human immunodeficiency viruses regulated by alternative trans-activators: genetic evidence for a novel non-transcriptional function of Tat in virion infectivity.EMBO J. 1994 Jun 15;13(12):2886-96. doi: 10.1002/j.1460-2075.1994.tb06583.x. EMBO J. 1994. PMID: 8026473 Free PMC article.
-
Effects of human chromosome 12 on interactions between Tat and TAR of human immunodeficiency virus type 1.J Virol. 1994 Oct;68(10):6505-13. doi: 10.1128/JVI.68.10.6505-6513.1994. J Virol. 1994. PMID: 8083988 Free PMC article.
-
A small circular TAR RNA decoy specifically inhibits Tat-activated HIV-1 transcription.Nucleic Acids Res. 1996 Oct 1;24(19):3733-8. doi: 10.1093/nar/24.19.3733. Nucleic Acids Res. 1996. PMID: 8871552 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources